Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to Teleflex.

In coronary vascular interventions, key products include the Pantera™ Lux™ Drug-Coated Balloon Catheter, the novel PK Papyrus™ Covered Coronary Stent for acute coronary artery perforations, and the ...

the novel PK Papyrus™ Covered Coronary Stent for acute coronary artery perforations, and the Orsiro™ Mission Drug Eluting Stent, an ultrathin drug-eluting stent with differentiated clinical ...

the novel PK Papyrus™ Covered Coronary Stent for acute coronary artery perforations, and the Orsiro™ Mission Drug Eluting Stent, an ultrathin drug-eluting stent with differentiated clinical ...

Notable additions include the Pantera™ Lux™ Drug-Coated Balloon Catheter and Orsiro™ Mission Drug-Eluting Stent for coronary interventions, as well as the Passeo™-18 Lux™ Peripheral Drug ...

the PK Papyrus covered coronary stent for acute coronary artery perforations; and the ultrathin Orsiro Mission drug-eluting stent For peripheral interventions, the Passeo-18 Lux peripheral drug-coated ...

1,2 The acquired business will expand the Teleflex Interventional portfolio to include a broad suite of vascular intervention devices such as drug-coated balloons, drug-eluting stents, covered ...

Background The River stent is the first stent specifically designed for intracranial venous sinuses. We report the 1-year results of the River trial, performed to obtain Humanitarian Device Exemption ...

According to the company, the trial evaluated the company’s River venous sinus stent for the treatment of idiopathic intracranial hypertension (IIH) in patients who are refractory or intolerant to ...

Stent retrievers are accepted as the most effective devices for intracranial thrombectomy. Objective To analyze the mechanical properties of stent retrievers, their behavior during retrieval, and ...